Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex.
A new multiparticulate system, with the potential for site-specific delivery to the colon, has been developed using ketoprofen as model drug. The system simultaneously exploits cyclodextrin complexation, to improve drug solubility, and vectorization in microspheres (MS) based on Ca-pectinate and chitosan. The effect of complexation with hydroxypropyl-beta-cyclodextrin (HPbetaCyd) and of chitosan presence on drug entrapment efficiency and release properties, as well on the drug permeation rate across Caco-2 cells has been investigated. Solid-state interactions between the components have been investigated by FTIR spectroscopy, differential scanning calorimetry and X-ray powder diffractometry. The morphology of MS was examined by scanning electron microscopy. Release studies revealed a different behaviour for MS containing drug alone or as complex: drug alone was released faster than in the presence of cyclodextrin from MS without chitosan, due to a reservoir effect. The opposite was found for MS containing chitosan, due to a competition effect between polymer and drug for the cyclodextrin. Cytotoxicity tests demonstrated the safety of these formulations. Permeation studies showed an increased permeation of the drug formulated as MS, particularly marked when it was used as complex, thus revealing an enhancing power of both cyclodextrin and chitosan with a synergistic effect in improving drug permeation.
Maestrelli
F
F
Department of Pharmaceutical Sciences, University of Florence, via Schiff 6, 50019 Sesto Fiorentino, Florence, Italy. francesca.maestrelli@unifi.it
Zerrouk
N
N
Cirri
M
M
Mennini
N
N
Mura
P
P
D000073738:2-Hydroxypropyl-beta-cyclodextrin; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry / Q000378:metabolism*; D018938:Caco-2 Cells; D002122:Calcium Chloride / Q000737:chemistry; D048271:Chitosan / Q000737:chemistry; D016861:Cyclooxygenase Inhibitors / Q000737:chemistry / Q000378:metabolism*; D004333:Drug Administration Routes; D006801:Humans; D007660:Ketoprofen / Q000737:chemistry; D008863:Microspheres; D010368:Pectins / Q000737:chemistry; D047392:beta-Cyclodextrins / Q000737:chemistry / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D047392:beta-Cyclodextrins; D000073738:2-Hydroxypropyl-beta-cyclodextrin; D010368:Pectins; D048271:Chitosan; D007660:Ketoprofen; D002122:Calcium Chloride